Literature DB >> 33658991

Comprehensive Analysis of CD4+ T Cell Responses to CMV pp65 Antigen Restricted by Single HLA-DR, -DQ, and -DP Allotype Within an Individual.

You-Seok Hyun1,2, Hyeong-A Jo1,2, Yong-Hun Lee1,2, Sun-Mi Kim3, In-Cheol Baek3, Hyun-Jung Sohn4, Hyun-Il Cho4, Tai-Gyu Kim1,2,3.   

Abstract

Within an individual, six different HLA class II heterodimers are expressed co-dominantly by two alleles of HLA-DR, -DQ, and -DP loci. However, it remained unclear which HLA allotypes were used in T cell responses to a given antigen. For the measurement of the CD4+ T cell responses restricted by a single HLA allotype, we established a panel of artificial antigen-presenting cells (aAPCs) expressing each single HLA allele of 20 HLA-DRB1, 16 HLA-DQ, and 13 HLA-DP alleles. CD4+ T cell responses to cytomegalovirus (CMV) pp65 restricted by single HLA class II allotype defined in 45 healthy donors. The average magnitude of CD4+ T cell responses by HLA-DR allotypes was higher than HLA-DQ and HLA-DP allotypes. CD4+ T cell responses by DRA*01:01/DRB1*04:06, DQA1*01:02/DQB1*06:02, DPA1*02:02/DPB1*05:01 were higher among the other alleles in each HLA-DR, -DQ, and -DP locus. Interestingly, the frequencies of HLA-DR alleles and the positivity of specific allotypes showed an inverse correlation. One allotype within individuals is dominantly used in CD4+ T cell response in 49% of donors, and two allotypes showed that in 7% of donors, and any positive response was detected in 44% of donors. Even if one individual had several dominant alleles, CD4+ T cell responses tended to be restricted by only one of them. Furthermore, CD8+ and CD4+ T cell responses by HLA class I and class II were correlated. Our results demonstrate that the CD4+ T cell preferentially use a few dominant HLA class II allotypes within individuals, similar to CD8+ T cell response to CMV pp65.
Copyright © 2021 Hyun, Jo, Lee, Kim, Baek, Sohn, Cho and Kim.

Entities:  

Keywords:  CD4+ T cells; HLA-DP; HLA-DQ; HLA-DR; MHC class II alleles; adaptive immunity; cytomegalovirus pp65 antigen; immunodominance

Mesh:

Substances:

Year:  2021        PMID: 33658991      PMCID: PMC7917246          DOI: 10.3389/fimmu.2020.602014

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  50 in total

1.  Sequence analysis of peptides bound to MHC class II molecules.

Authors:  A Rudensky; P Preston-Hurlburt; S C Hong; A Barlow; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

2.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

3.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

4.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

5.  HLA and Disease Associations in Koreans.

Authors:  Stephen Ahn; Hee-Back Choi; Tai-Gyu Kim
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

6.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

7.  A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.

Authors:  Cecilia S Lindestam Arlehamn; Denise M McKinney; Chelsea Carpenter; Sinu Paul; Virginie Rozot; Edward Makgotlho; Yolande Gregg; Michele van Rooyen; Joel D Ernst; Mark Hatherill; Willem A Hanekom; Bjoern Peters; Thomas J Scriba; Alessandro Sette
Journal:  PLoS Pathog       Date:  2016-07-13       Impact factor: 6.823

8.  HLA class I haplotype diversity is consistent with selection for frequent existing haplotypes.

Authors:  Idan Alter; Loren Gragert; Stephanie Fingerson; Martin Maiers; Yoram Louzoun
Journal:  PLoS Comput Biol       Date:  2017-08-28       Impact factor: 4.475

9.  The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation.

Authors:  Dolores Grosso; Benjamin Leiby; Matthew Carabasi; Joanne Filicko-O'Hara; Sameh Gaballa; William O'Hara; John L Wagner; Neal Flomenberg
Journal:  Front Oncol       Date:  2019-09-17       Impact factor: 6.244

10.  Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus.

Authors:  Elizabeth K Day; Andrew J Carmichael; Ineke J M ten Berge; Edward C P Waller; J G Patrick Sissons; Mark R Wills
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

View more
  4 in total

1.  Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease.

Authors:  Kensuke Suga; Aya Nishiwaki; Takayuki Nakamura; Shin-Ichiro Kagami
Journal:  Rheumatol Int       Date:  2022-08-30       Impact factor: 3.580

2.  Identification of Naturally Processed Epitope Region Using Artificial APC Expressing a Single HLA Class I Allotype and mRNA of HCMV pp65 Antigen Fragments.

Authors:  Hong-Seon Pyo; Cheol-Hwa Hong; Haeyoun Choi; In-Cheol Baek; Tai-Gyu Kim
Journal:  Vaccines (Basel)       Date:  2022-05-16

3.  Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4+ T cell responses restricted by single HLA class II allotype in an individual.

Authors:  Yong-Hun Lee; You-Seok Hyun; Hyeong-A Jo; In-Cheol Baek; Sun-Mi Kim; Hyun-Jung Sohn; Tai-Gyu Kim
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

4.  Comprehensive Analysis of CD4+ T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II.

Authors:  You-Seok Hyun; Yong-Hun Lee; Hyeong-A Jo; In-Cheol Baek; Sun-Mi Kim; Hyun-Jung Sohn; Tai-Gyu Kim
Journal:  Front Immunol       Date:  2022-01-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.